UK renal registry 11th annual report (December 2008): Chapter 10 Biochemistry profile of patients receiving dialysis in the UK in 2007: National and centre-specific analyses

Nephron - Clinical Practice

Volumn 111, Issue SUPPL. 1, 2009, Pages

  Hodsman, Alex ^a   Lamb, Edmund J ^b   Steenkamp, Retha ^a   Warwick, Graham ^c  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b KENT AND CANTERBURY HOSPITAL   (United Kingdom)

^c LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bicarbonate; Biochemical variables; Calcium; Cholesterol; Dialysis; Haemodialysis; Parathyroid hormone; Peritoneal Dialysis; Phosphate; Quality improvement

Indexed keywords

BICARBONATE; CALCIUM; CHOLESTEROL; PARATHYROID HORMONE;

ARTICLE; COHORT ANALYSIS; HUMAN; MEDICAL AUDIT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REGISTER; UNITED KINGDOM;

ADULT; BIOLOGICAL MARKERS; CALCIUM; CHOLESTEROL; FEMALE; GREAT BRITAIN; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHOSPHATES; REGISTRIES; RENAL DIALYSIS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 68249103399     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209999     Document Type: Article

References (13)

1. Renal Association Clinical practice guidelines. 4th edition. Module 2, complications. www.renal.org/guidelines. 2007.
2. Ansell, D.F., J. Feest, T.G. Tomson, C. Williams, A.J. Warwick, G., UK Registry Report. Chapter 9 Management of biochemical variables. 2007, UK Renal Registry: Bristol UK.
3. Ansell, D.B., C. Feest, T.G., UK Renal Registry Report. Chapter 3. 2002.
4. Lamb, E.J., S. Vickery, and A.R. Ellis, Parathyroid hormone, kidney disease, evidence and guidelines. Ann Clin Biochem, 2007.44(Pt1):p.1-4.
5. National Kidney Foundation KDOQI (TM) Clinical Practice Guidelines. Available from: http://www.kidney.org/professionals/KDOQI.
6. Spiegelhalter, D.J., Funnel plots for comparing institutional performance. Stat Med, 2005.24(8):p.1185-202.
7. Kalantar-Zadeh, K., et al., Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int, 2006.70(4):p.771-80.
8. Melamed, M.L., et al., Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int, 2006.70(2):p.351-7.
9. Noordzij, M., et al., The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis, 2005.46(5): p.925-32.
10. Stevens, L.A., et al., Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol, 2004.15(3):p.770-9.
11. Block, G.A., et al., Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol, 2004.15(8):p.2208-18.
12. Danese, M.D., et al., Consistent Control of Mineral and Bone Disorder in Incident Hemodialysis Patients. Clin J Am Soc Nephrol, 2008.2:p.2.
13. Ansell, D.F., T.G. (eds), Renal Registry 7th Annual Report. In chapter 6: Adequacy of haemodialysis and serum bicarbonate. 2004.p.59-86.